Ocular Therapeutix reports $11.5 million net loss in third quarter

Ocular Therapeutix reported a net loss of $11.5 million, or $0.47 per share, in the third quarter compared with a net loss of $7.3 million, or $0.48, per share in the same quarter of 2014, according to a press release. Product sales from ReSure sealant and other collaborations with corporate partners generated a revenue of $0.43 million in the third quarter. Approximately $0.14 million in revenue was recorded a year ago.